Company news

Wellnex Life Ltd news in 2024

Wellnex Life Ltd's news releases, calls and decks from 2024, newest first.

View company

Completion of Placement

December 20, 2024

Update on Pain Away Deferred Consideration

November 4, 2024

Appendix 4C and Quarterly Report for Sep 2024 Quarter

October 31, 2024

Update on LSE Dual Listing

October 23, 2024

Wellnex Life Releases FY24 Annual Report

September 30, 2024

Appointment of Chair

September 9, 2024

Wellnex Releases FY24 Appendix 4E & Preliminary Report

August 30, 2024

Notice of Extraordinary General Meeting/Proxy Form

August 28, 2024

Launch of Medicinal Cannabis Brand Wellness Life for SAS

August 15, 2024

Further Update to Announcement on Opening Order from the UK

August 15, 2024

Wellnex Receives Opening Order in the UK from Haleon

August 14, 2024

Appendix 4C and Quarterly Report for Jun 2024 Quarter

July 31, 2024

Proposed issue of securities - WNX

July 24, 2024

Wellnex Raises $2m Placement and Update on LSE Dual Listing

July 24, 2024

Trading Update - June

June 30, 2024

Trading Update - May

June 12, 2024

Wellnex Launches Medicinal Cannabis Brand Wellness Life

June 4, 2024

Wellnex Re-engages CW NZ and Supplies First Pain Away Order

May 23, 2024

Business Update

May 8, 2024

Launch of Additional Wakey Wakey Products

May 7, 2024

Appendix 4C and Quarterly Report for Mar 2024 Quarter

April 30, 2024

Wellnex to Dual List on the London Stock Exchange

April 22, 2024

Reinstatement to Official Quotation

March 7, 2024

Cleansing Prospectus

March 7, 2024

UK Reg Approval for Paracetamol Soft Gel Liquid Analgesic

February 14, 2024

Distribution Agreement Signed with Elysian

February 5, 2024

Appendix 4C and Quarterly Report for Dec 2023 - Correction

January 31, 2024

Appendix 4C and Quarterly Report for Dec 2023 Quarter

January 31, 2024

WNX Signs International Distribution Agreement with Homart

January 2, 2024

Decks in 2024